Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2017 June;42(2) > Minerva Endocrinologica 2017 June;42(2):151-63

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW  ENDOCRINE AND METABOLIC DISORDERS INTERPLAYING WITH NON-ALCOHOLIC FATTY LIVER DISEASE 

Minerva Endocrinologica 2017 June;42(2):151-63

DOI: 10.23736/S0391-1977.16.02583-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Adrenal disorders and non-alcoholic fatty liver disease

Labrini PAPANASTASIOU 1, Stelios FOUNTOULAKIS 1, Ioannis-Anastasios VATALAS 2

1 Department of Endocrinology and Diabetes Center, Athens General Hospital ”G. Gennimatas“, Athens, Greece; 2 Unit of Translation and Clinical Research in Endocrinology, University of Athens Medical School, Athens, Greece


PDF


Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the developed world and its pathogenesis is complex and multifactorial. It is considered the hepatic manifestation of the metabolic syndrome and is the leading cause of hepatic cirrhosis. This review aims to present current knowledge on the involvement of the adrenal glands in the development of NAFLD. Clinical and animal studies have shown that excess glucocorticoids (GC) have been implicated in the pathogenesis of NAFLD. Patients with NAFLD seem to have a subtle chronic activation of the hypothalamic pituitary adrenal axis leading to a state of subclinical hypercortisolism. Regulators of GC such as 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), an enzyme that regenerates cortisol from inactive cortisone, and 5α/5β-reductases, enzymes that increase cortisol clearance, are implicated in the development of NAFLD by amplifying local GC action. Adrenal androgen (dehydroepiandrosterone) abnormalities and increased aldosterone levels may also have a role in the development of NAFLD whereas the contribution of adrenergic signaling in NAFLD pathogenesis remains unclear.


KEY WORDS: Adrenal glands - Non-alcoholic fatty liver disease - Glucocorticoids - Aldosterone - Dehydroepiandrosterone - Catecholamines

inizio pagina